(S (NP (NN Glaucoma)) (VP (VBZ is) (NP (NP (DT the) (VBG leading) (NN cause)) (PP (IN of) (NP (NP (ADJP (JJ irreversible) (CC but) (JJ preventable)) (NN blindness)) (PP (IN in) (NP (DT the) (NN world))))))) (. .))
(S (NP (PRP$ Its) (JJ major) (JJ treatable) (NN risk) (NN factor)) (VP (VBZ is) (NP (DT the) (JJ intra-ocular) (NN pressure)) (, ,) (SBAR (IN although) (S (NP (JJ other) (NNS biomarkers)) (VP (VBP are) (VP (VBG being) (VP (VBN explored) (S (VP (TO to) (VP (VB improve) (NP (NP (DT the) (NN understanding)) (PP (IN of) (NP (NP (DT the) (NN pathophysiology)) (PP (IN of) (NP (DT the) (NN disease))))))))))))))) (. .))
(S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (ADVP (RB recently)) (VP (VBN observed) (SBAR (IN that) (S (NP (NN glaucoma)) (VP (VBZ induces) (NP (NP (NNS changes)) (PP (IN in) (NP (DT the) (JJ ocular) (NNS hemodynamics)))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NP (PRP$ its) (NNS effects)) (PP (IN on) (NP (NP (DT the) (JJ functional) (NN behavior)) (PP (IN of) (NP (DT the) (JJ retinal) (NNS arterioles)))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied) (ADVP (RB yet))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (NP (PRP we)) (VP (VBP propose) (NP (DT a) (JJ first) (NN approach)) (PP (IN for) (S (VP (VBG characterizing) (NP (DT those) (NNS changes)) (S (VP (VBG using) (NP (JJ computational) (NNS hemodynamics)))))))) (. .))
(S (NP (DT The) (JJ retinal) (NN blood) (NN flow)) (VP (VBZ is) (VP (VBN simulated) (S (VP (VBG using) (NP (DT a) (NN 0D) (NN model)) (PP (IN for) (NP (NP (DT a) (ADJP (JJ steady) (, ,) (JJ incompressible)) (ADJP (AFX non) (JJ Newtonian)) (NN fluid)) (PP (IN in) (NP (JJ rigid) (NNS domains))))))))) (. .))
(S (NP (DT The) (NN simulation)) (VP (VBZ is) (VP (VBN performed) (PP (IN on) (NP (NP (ADJP (NN patient) (HYPH -) (JJ specific)) (JJ arterial) (NNS trees)) (VP (VBN extracted) (PP (IN from) (NP (NN fundus) (NNS images)))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBP propose) (NP (DT a) (JJ novel) (NN feature) (NN representation) (NN technique)) (S (VP (TO to) (VP (VB comprise) (NP (NP (DT the) (NNS outcomes)) (PP (IN of) (NP (DT the) (NN simulation) (NN stage)))) (PP (IN into) (NP (NP (DT a) (NML (VBN fixed) (NN length)) (NN feature) (NN vector)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (NN classification) (NNS studies)))))))))))))) (. .))
(S (NP (NP (PRP$ Our) (NNS experiments)) (PP (IN on) (NP (NP (DT a) (JJ new) (NN database)) (PP (IN of) (NP (NN fundus) (NNS images)))))) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (NN approach)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB capture) (NP (JJ representative) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NNS hemodynamics)) (PP (IN of) (NP (JJ glaucomatous) (NNS patients))))))))))))) (. .))
(S (NP (NN Code) (CC and) (NNS data)) (VP (VBP are) (ADJP (RB publicly) (JJ available) (SBAR (IN in) (S (NP (DT this)) (VP (VBZ https) (NP (NN URL))))))))
